Variant report

Variant	rs11119778
Chromosome Location	chr1:211803723-211803724
allele	C/T
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

TF binding
region (count:0)
CpG islands
(count:0)
Chromatin interactive
region (count:10)
LncRNA
region (count:0)
Mature miRNA
region (count: 0)
miRNA target
sites (count:0)

No data

(count:10 , 50 per page) page: 1

No.	Distal block	Cell Line	Cell type
1	chr1:211779113..211779919-chr1:211803601..211804198,2	K562	blood:
2	chr1:211802788..211806999-chr1:211814684..211819078,4	K562	blood:
3	chr1:211782443..211790536-chr1:211800686..211806134,8	K562	blood:
4	chr1:211750683..211751727-chr1:211803429..211804168,3	K562	blood:
5	chr1:211688552..211689424-chr1:211803240..211804149,2	K562	blood:
6	chr1:211793145..211800078-chr1:211800841..211805263,11	K562	blood:
7	chr1:211741510..211743942-chr1:211802313..211805190,2	K562	blood:
8	chr1:211751888..211754442-chr1:211802354..211807016,4	K562	blood:
9	chr1:211723836..211726328-chr1:211802302..211805262,2	K562	blood:
10	chr1:211751862..211753388-chr1:211800934..211803854,2	K562	blood:

No data

Variant related genes	Relation type
ENSG00000228792	Chromatin interaction
ENSG00000170385	Chromatin interaction

rs_ID	r²[population]
rs11576130	0.96[ASN][1000 genomes]
rs12087826	1.00[YRI][hapmap];0.95[AFR][1000 genomes];0.84[AMR][1000 genomes];0.97[ASN][1000 genomes]
rs12736496	0.83[CEU][hapmap]
rs1530400	0.85[ASN][1000 genomes]
rs4951415	0.83[EUR][1000 genomes]
rs4951537	0.81[CEU][hapmap]
rs6540697	0.96[ASN][1000 genomes]
rs6660850	0.96[ASN][1000 genomes]
rs6675796	0.97[ASN][1000 genomes]
rs6682640	0.89[ASN][1000 genomes]
rs7551341	0.86[ASN][1000 genomes]
rs7553718	0.86[ASN][1000 genomes]
rs7554315	0.85[ASN][1000 genomes]

Chromatin state (count:45 , 50 per page) page: 1

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr1:211798600-211803800	Weak transcription	Hela-S3	cervix
2	chr1:211800000-211807200	Enhancers	Fetal Heart	heart
3	chr1:211802000-211806400	Weak transcription	Ganglion Eminence derived primary cultured neurospheres	brain
4	chr1:211802800-211804200	Enhancers	ES-UCSF4 Cell Line	embryonic stem cell
5	chr1:211803000-211804800	Enhancers	Fetal Intestine Small	intestine
6	chr1:211803400-211803800	Enhancers	iPS-15b Cell Line	embryonic stem cell
7	chr1:211803400-211803800	Enhancers	Right Atrium	heart
8	chr1:211803400-211804000	Enhancers	Cortex derived primary cultured neurospheres	brain
9	chr1:211803400-211804000	Bivalent Enhancer	NHEK	skin
10	chr1:211803400-211804200	Enhancers	H1 Derived Mesenchymal Stem Cells	ES cell derived
11	chr1:211803400-211804200	Bivalent Enhancer	Primary hematopoietic stem cells G-CSF-mobilized Male	--
12	chr1:211803400-211804200	Flanking Bivalent TSS/Enh	HepG2	liver
13	chr1:211803400-211804800	Enhancers	Fetal Intestine Large	intestine
14	chr1:211803400-211804800	Enhancers	Placenta	Placenta
15	chr1:211803400-211804800	Flanking Active TSS	K562	blood
16	chr1:211803400-211805000	Enhancers	ES-WA7 Cell Line	embryonic stem cell
17	chr1:211803400-211805000	Bivalent Enhancer	Foreskin Melanocyte Primary Cells skin03	Skin
18	chr1:211803400-211806000	Enhancers	Breast Myoepithelial Primary Cells	Breast
19	chr1:211803400-211807000	Enhancers	Ovary	ovary
20	chr1:211803400-211807600	Bivalent Enhancer	Foreskin Melanocyte Primary Cells skin01	Skin
21	chr1:211803400-211807600	Enhancers	Fetal Adrenal Gland	Adrenal Gland
22	chr1:211803600-211803800	Enhancers	Left Ventricle	heart
23	chr1:211803600-211803800	Bivalent Enhancer	HMEC	breast
24	chr1:211803600-211804000	Flanking Active TSS	ES-I3 Cell Line	embryonic stem cell
25	chr1:211803600-211804000	Enhancers	H1 BMP4 Derived Trophoblast Cultured Cells	ES cell derived
26	chr1:211803600-211804000	Enhancers	H1 Derived Neuronal Progenitor Cultured Cells	ES cell derived
27	chr1:211803600-211804000	Enhancers	hESC Derived CD56+ Mesoderm Cultured Cells	ES cell derived
28	chr1:211803600-211804000	Flanking Active TSS	HUES6 Cell Line	embryonic stem cell
29	chr1:211803600-211804000	Enhancers	iPS DF 6.9 Cell Line	embryonic stem cell
30	chr1:211803600-211804000	Bivalent Enhancer	Primary hematopoietic stem cells short term culture	blood
31	chr1:211803600-211804000	Bivalent/Poised TSS	Foreskin Fibroblast Primary Cells skin02	Skin
32	chr1:211803600-211804000	Enhancers	Gastric	stomach
33	chr1:211803600-211804000	Active TSS	Right Ventricle	heart
34	chr1:211803600-211804000	Enhancers	Spleen	Spleen
35	chr1:211803600-211804200	Enhancers	H1 Cell Line	embryonic stem cell
36	chr1:211803600-211804200	Bivalent Enhancer	Primary hematopoietic stem cells G-CSF-mobilized Female	--
37	chr1:211803600-211804200	Flanking Bivalent TSS/Enh	Foreskin Keratinocyte Primary Cells skin02	Skin
38	chr1:211803600-211804200	Flanking Active TSS	Foreskin Keratinocyte Primary Cells skin03	Skin
39	chr1:211803600-211804200	Enhancers	Esophagus	oesophagus
40	chr1:211803600-211804400	Enhancers	hESC Derived CD184+ Endoderm Cultured Cells	ES cell derived
41	chr1:211803600-211804400	Enhancers	IMR90 fetal lung fibroblasts Cell Line	lung
42	chr1:211803600-211804800	Enhancers	iPS DF 19.11 Cell Line	embryonic stem cell
43	chr1:211803600-211805000	Enhancers	Fetal Lung	lung
44	chr1:211803600-211807200	Enhancers	Fetal Muscle Trunk	muscle
45	chr1:211803600-211807200	Enhancers	Fetal Muscle Leg	muscle

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links